What is the recommended tapering schedule for discontinuing Lexapro (escitalopram) from a 10 mg dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tapering Lexapro from 10 mg

Reduce Lexapro by 25% of the current dose every 1-2 weeks initially (from 10 mg to 7.5 mg, then to approximately 5.6 mg, etc.), extending to 10% reductions as you approach lower doses, with a minimum total taper duration of 4 weeks but ideally several months. 1

Recommended Tapering Protocol

The hyperbolic (percentage-based) tapering approach is superior to linear tapering because it reduces the biological effect at serotonin transporters in a more even manner, minimizing withdrawal symptoms. 1, 2

Initial Phase (Higher Doses)

  • Start by reducing 25% of the current dose (not the original dose) every 1-2 weeks 1
  • From 10 mg: reduce to 7.5 mg for 1-2 weeks, then to approximately 5.6 mg for 1-2 weeks 1

Later Phase (Lower Doses)

  • As you approach lower doses, slow down to 10% reductions of the current dose 1
  • This means progressively smaller absolute dose reductions as the total dose decreases 2
  • Final doses before complete cessation may need to be very small (potentially 1-2 mg or less) to prevent a large drop in serotonin transporter occupancy 2, 3

Timeline Considerations

  • Minimum duration: 4 weeks, but longer tapers (months) show greater success in reducing withdrawal symptoms 1, 2
  • Escitalopram has a relatively short half-life, making gradual tapering particularly important 4
  • Some patients may benefit from extending the taper over several months, particularly if they've been on the medication long-term 5

Managing Withdrawal Symptoms

Common Symptoms to Monitor

  • Dizziness and light-headedness 4
  • Nausea, flu-like symptoms, fatigue 4
  • Sensory disturbances (paresthesias) 5
  • Sleep disturbances, insomnia 4, 5
  • Mood disturbances, anxiety, irritability, crying spells 4, 5

If Withdrawal Symptoms Emerge

  • Pause the taper and maintain the current dose until symptoms stabilize 1
  • If symptoms are severe, return to the previous higher dose 5
  • Once stable, resume tapering with smaller reductions (e.g., 10% instead of 25%) 1
  • Extend the time between dose reductions to 3-4 weeks or longer 1

Monitoring Requirements

  • Follow up at least monthly during the taper, with more frequent contact during difficult phases 1
  • Assess for withdrawal symptoms versus return of underlying depression 5
  • Screen for mood changes and ensure symptoms are not being mistaken for relapse 4, 6

Critical Pitfalls to Avoid

Don't Taper Too Quickly

  • Traditional guidance recommending 2-4 week tapers shows minimal benefit over abrupt discontinuation and is often not tolerated 2
  • Tapers over months are more successful 2

Don't Abandon the Patient

  • Maintain frequent follow-up throughout the process 1
  • The therapeutic relationship is crucial even if tapering proves difficult 1

Don't Use Linear Dose Reductions

  • Reducing by the same absolute amount (e.g., 2.5 mg every week) creates disproportionately large reductions in biological effect as doses get lower 2
  • Always reduce by a percentage of the current dose, not the original dose 1

Don't Mistake Withdrawal for Relapse

  • Withdrawal symptoms can last days to months and may be misdiagnosed as depression recurrence 4, 5
  • This misdiagnosis can lead to unnecessary long-term medication 2

Patient-Centered Approach

The taper rate must be determined by the patient's tolerance, not a rigid schedule. 1 Pauses in the taper are acceptable and often necessary when withdrawal symptoms emerge. 1 Some patients may require even slower tapers (10% per month or less) depending on their individual response. 2

References

Guideline

Tapering Off Escitalopram

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Research

Discontinuing antidepressants: Pearls and pitfalls.

Cleveland Clinic journal of medicine, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.